ProfileGDS5822 / ILMN_1242870
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 17% 6% 13% 5% 2% 1% 36% 21% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.217
GSM1276600PDAC Late Ablation Control 210.46
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.613
GSM1276603PDAC Late Ablation 25.95
GSM1276604PDAC Late Ablation 33.52
GSM1303940PDAC Late Ablation_anti-CTLA4 13.91
GSM1303941PDAC Late Ablation_anti-CTLA4 217.336
GSM1303942PDAC Late Ablation_anti-CTLA4 311.121